GenesisCare remains committed to ensuring that cancer patients can safely continue to receive the care they need in our centres. Currently all of our centres and clinics are operating without delay.
We are closely monitoring the coronavirus (COVID-19) pandemic globally, implementing the latest Government advice, and are adding extra precautionary measures to maintain a safe environment for our patients and teams.
We’ve adopted a number of measures so we can continue to provide all services and consultations in a safe environment for all patients and referrers. Our commitment to this will evolve during the pandemic, and our focus continues to be ensuring the best possible outcomes for all our patients and staff.
At GenesisCare, treatment continues as usual within our centres and we are prepared to treat all patients without delay or compromise. We remain committed to ensuring that cancer patients can continue to receive the care they need in our centres. Currently all our centres are operating as usual and we are continuing to treat patients without delay.
In order to ensure patients can quickly access the diagnostic tests and treatment they need, we are continuing to to run rapid access diagnostic clinics for breast, urology and prostate patients in Cambridge, Maidstone, Milton Keynes, Oxford and Windsor centres.
Additionally, it’s also important for everyone to try to keep their wellbeing front and centre during what can understandably be a stressful time. This could mean remaining active, calling a friend or doing something else you enjoy. GenesisCare is here to support our people, our patients and our communities in whatever way we can, so please reach out to your local centre if you have any questions, comments or concerns.
GenesisCare delivers care both privately and on behalf of governments in many locations around the world. We acknowledge the demand that this outbreak is having on the broader public health system internationally and will continue to work closely with health departments to provide rapid access to high quality oncology and cardiology care.